a(CHEBI:"NMDA receptor antagonist") positiveCorrelation bp(GO:cognition)

View Subject View Object

PubMed:21882945

There are no cures for any tauopathy. Neuroprotective agents, such as acetylcholinesterase inhibitors and NMDA antagonists, have been approved for use in the clinic, based on their ability to slow the rate of cognitive decline in patients with moderate to severe AD (reviewed in [36])

Related Edges 3

• a(PUBCHEM:134222899) positiveCorrelation bp(GO:cognition)
• bp(GO:cognition) positiveCorrelation a(PUBCHEM:134222899)
• bp(GO:cognition) positiveCorrelation a(CHEBI:"NMDA receptor antagonist")

MeSH

Alzheimer Disease

BEL Commons is developed and maintained in an academic capacity by Charles Tapley Hoyt and Daniel Domingo-Fernández at the Fraunhofer SCAI Department of Bioinformatics with support from the IMI project, AETIONOMY. It is built on top of PyBEL, an open source project. Please feel free to contact us here to give us feedback or report any issues. Also, see our Publishing Notes and Data Protection information.

If you find BEL Commons useful in your work, please consider citing: Hoyt, C. T., Domingo-Fernández, D., & Hofmann-Apitius, M. (2018). BEL Commons: an environment for exploration and analysis of networks encoded in Biological Expression Language. Database, 2018(3), 1–11.

---